Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Trinidad & Tobago Wellness Today.
Press releases published on July 17, 2025
Globus Medical Schedules Second Quarter Earnings Release and Conference Call
GlobeNewswire
·
July 17, 2025
AUDUBON, Pa., July 17, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal technology company, will announce its financial results for the second quarter ended June 30, 2025 after the market close on Thursday, August 7, …
Basel Medical Group Putting On Hold On The Acquisition of BTC Digital Asset
GlobeNewswire
·
July 17, 2025
Singapore, July 17, 2025 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (Nasdaq: BMGL or the “Company”), today announced that it is putting on hold on the acquisition of BTC digital asset. After thorough discussions, Basel and the consortium of Bitcoin (BTC) …
Omada Health to Announce Second Quarter 2025 Financial Results and Host Conference Call on August 7, 2025
GlobeNewswire
·
July 17, 2025
SAN FRANCISCO, July 17, 2025 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual between-visit healthcare provider, today announced that it will release its second quarter 2025 results on Thursday, August 7, 2025, after market close, and host a …
Hapbee Announces Insider Purchase of $1 Million USD via Closing of Non-Brokered Private Placement
GlobeNewswire
·
July 17, 2025
VANCOUVER, British Columbia, July 17, 2025 (GLOBE NEWSWIRE) -- Hapbee Technologies, Inc. (TSXV: HAPB | OTCID: HAPBF) (“Hapbee” or the “Company”), a leading wearable wellness technology company, is pleased to announce that it has now closed its previously …
LifeStance to Host Second Quarter 2025 Earnings Conference Call on August 7, 2025
GlobeNewswire
·
July 17, 2025
SCOTTSDALE, Ariz., July 17, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation’s largest providers of outpatient mental health care, will issue its second quarter 2025 earnings release before the market opens on …
Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
July 17, 2025
CHASKA, Minn., July 17, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”) a fully integrated contract development and manufacturing organization (“CDMO”), today announced that on July 11, 2025, the Lifecore compensation …
Exagen Inc. Appoints Chas McKhann to Board of Directors
GlobeNewswire
·
July 17, 2025
CARLSBAD, Calif., July 17, 2025 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of innovative autoimmune testing solutions, announced today the appointment of Chas McKhann to its Board of Directors, effective July 17, 2025. Mr. McKhann is …
NKGen Biotech and HekaBio Enter Strategic Partnership to Bring Novel NK Cell Therapy to Japan
GlobeNewswire
·
July 17, 2025
In connection with HekaBio’s recently announced strategic investment in NKGen, the partnership will expedite the regulatory, manufacturing, and commercial development of NKGen’s autologous NK cell therapy, troculeucel, in Japan. Under Japan’s Regenerative …
Updated Data from Eledon Pharmaceuticals’ Ongoing Phase 1b Trial of Tegoprubart in Patients Undergoing Kidney Transplantation to be Presented at the World Transplant Congress 2025
GlobeNewswire
·
July 17, 2025
IRVINE, Calif., July 17, 2025 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (Nasdaq: ELDN) today announced that updated clinical data from its ongoing open-label Phase 1b study evaluating tegoprubart for the prevention of rejection in …
Health care advocates afraid of major cuts and privatization hold shadow summit and rally at Council of the Federation next week
GlobeNewswire
·
July 17, 2025
HUNTSVILLE, Ontario, July 17, 2025 (GLOBE NEWSWIRE) -- Outside the Council of the Federation and the gathering of First Ministers, public health care advocates from across Canada will be joining a shadow summit, rally, and car cavalcade. Attendees include …
GSK’s Linerixibat Poised to Address Substantial Unmet Need for the Treatment of Pruritus Associated with Primary Biliary Cholangitis, According to Spherix Global Insights
GlobeNewswire
·
July 17, 2025
EXTON, PA, July 17, 2025 (GLOBE NEWSWIRE) -- The treatment landscape for primary biliary cholangitis (PBC) has undergone a marked transformation over the past year, driven by the recent approvals of Gilead’s Livdelzi (seladelpar) and Ipsen’s Iqirvo ( …
Global Motor Neuron Disease Treatment Market to Exhibit Substantial Growth at a CAGR of ~6% by 2032 | DelveInsight
GlobeNewswire
·
July 17, 2025
New York, USA, July 17, 2025 (GLOBE NEWSWIRE) -- Global Motor Neuron Disease Treatment Market to Exhibit Substantial Growth at a CAGR of ~6% by 2032 | DelveInsight The motor neuron disease treatment market is witnessing substantial growth, primarily fueled …
Dementia Associated with Alzheimer’s Disease Drug Development Surges with 180+ Companies Pushing New Therapeutic Frontiers | DelveInsight
GlobeNewswire
·
July 17, 2025
New York, USA, July 17, 2025 (GLOBE NEWSWIRE) -- Dementia Associated with Alzheimer’s Disease Drug Development Surges with 180+ Companies Pushing New Therapeutic Frontiers | DelveInsight Dementia associated with Alzheimer’s disease is a progressive …
Heartflow Unveils Landmark DECIDE Registry Data Demonstrating Impact of Heartflow Plaque Analysis on Coronary Artery Disease Medical Management
GlobeNewswire
·
July 17, 2025
MONTREAL, July 17, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc., the leader in AI technology for coronary artery disease (CAD), today announced new data for its AI-enabled Heartflow Plaque Analysis, including final primary endpoint data from the DECIDE …
OSE Immunotherapeutics lance une Newsletter pour les investisseurs individuels
GlobeNewswire
·
July 17, 2025
OSE Immunotherapeutics Launches Newsletter for Individual Shareholders NANTES, France, July 17, 2025, 6:30pm CET – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), a biotech company dedicated to developing first-in-class assets in immuno- …
OSE Immunotherapeutics lance une Newsletter pour les investisseurs individuels
GlobeNewswire
·
July 17, 2025
OSE Immunotherapeutics lance une Newsletter pour les investisseurs individuels NANTES, France, 17 juillet 2025, 18h30 – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), société de biotechnologie qui développe des produits first-in-class en …
MYOS PET and Leading Veterinarian Urge Action as Weather Extremes Impact Senior Pet Muscle Health
GlobeNewswire
·
July 17, 2025
CEDAR KNOLLS, N.J., July 17, 2025 (GLOBE NEWSWIRE) -- With climate changes becoming more severe, veterinary sports medicine and rehabilitation expert Dr. Kelly Fishman, DVM, CVA, CCRT, warns that summer heat waves and winter freezes are silently …
Oncotelic Therapeutics Highlights Peer‑Reviewed Publication Linking TGFB2 to Survival in Younger Pancreatic Cancer Patients
GlobeNewswire
·
July 17, 2025
Data support further evaluation of investigational antisense OT‑101 (trabedersen) as a TGFB2‑targeted approach in pancreatic ductal adenocarcinoma (PDAC). AGOURA HILLS, Calif., July 17, 2025 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (OTCQB: OTLC) (“ …
AI-Supported, Single-Center Cancer Model from Liv Hospital
GlobeNewswire
·
July 17, 2025
Photo: Liv Hospital via FL Communications ISTANBUL, July 17, 2025 (GLOBE NEWSWIRE) -- The “single-center oncology model,” implemented by only a select number of institutions worldwide, is being carried out with advanced technology and artificial …
Professional Credit Renews HFMA Peer Review Designation
GlobeNewswire
·
July 17, 2025
CHICAGO, July 17, 2025 (GLOBE NEWSWIRE) -- The Healthcare Financial Management Association (HFMA) today announced that, following rigorous review, Professional Credit has once again achieved the “Peer Reviewed by HFMA®” designation for its Healthcare …